Blood Advances
Publisher: Elsevier · ISSN 2473-9529 · 99 articles
- Quantitative and mutational properties in the ctDNA uncovered by systemic inflammation in large B-cell lymphoma
- Impact of Age on Real-World Outcomes of Bispecific Antibodies in Patients with Relapsed Refractory DLBCL: CUBIC Consortium Analysis
- Real World Comparison of Asciminib Versus Ponatinib in Chronic Myeloid Leukemia with Propensity Score–Matched Analysis
- Nodal peripheral T-cell lymphoma: a prognostic index developed by the T-cell project
- Diagnosis and management of acute myeloid leukemia with mutated CEBPA using CEBPA-Trass, a targeted sequencing approach
- Dasatinib in pediatric patients with chronic myeloid leukemia in chronic phase: long-term efficacy and endocrine analysis
- Cardiovascular risk and endothelial injury in hemophilia
- A Roadmap for Developing and Implementing Duffy Null-Specific Reference Intervals
- Trafficking Dynamics of Steady State Versus Mobilized Hematopoietic Stem and Progenitor Cells in Non-Human Primates
- Low Uptake of Guideline-Recommended MRI Screening for Silent Cerebral Infarcts over the Lifespan in Sickle Cell Anemia
- Treatment journey and outcomes of patients with RRMM after quadruple-class exposure: a critical unmet need
- Assessing Differences in Timeliness of Emergency Department Pain Treatment for Adult Sickle Cell Pain and Renal Colic.
- Iron Deficiency in Children Across Ferritin Methods
- Combined inhibition of BCL2 activity and CD28 signaling to prevent graft-versus-host disease
- Targeting smoldering myeloma and monoclonal gammopathy of undetermined significance using multi-antigen specific T cells
- Hematologic care for transgender and gender-diverse people
- Affordable cure within reach for thalassemia
- Duffy-null screening in children: testing for all?
- The diagnosis of iron deficiency: progress toward consensus
- NLRC4 inflammasome: a key driver in TET2-deficient MDS
- Heterogeneity and GRADE in recurrent VTE prognosis
- Looking beyond the perfect (mis)match
- Risk factors for CRS and ICANS with bispecific antibodies for aggressive lymphomas
- Evaluation of modern hematology-oncology home call: optimizing patient care, physician well-being, and trainee education
- Unfolded protein response signaling promotes myeloid cell production and cooperates with oncogenic mutation
- Early response and genetics define relapse risk after frontline blinatumomab in childhood B-ALL: a cohort study
- A hemoglobin >120 g/L trends toward improved survival without increasing vascular events in patients with MDS treated with ESAs
- Novel KIR2DS4:HLA-B∗35 interaction predicts HLA-B∗35+ patient survival after hematopoietic stem cell transplant
- A curative-intent treatment program in older AML: mature posttransplant results from the VEN-DEC GITMO study
- The hematology workforce in the United States: past, present, and strategies for the future